PP231 Development of a blood-based digital PCR assay using novel DNA methylation biomarkers for detecting early lung cancer
Abstract
Early detection and treatment monitoring are crucial to improve clinical outcomes in lung cancer. Circulating tumor DNA (ctDNA) has rapidly emerged as a promising non-invasive tool, yet clinically validated biomarkers with high specificity and sensitivity remain limited. This study aimed to develop and validate a digital PCR-based liquid biopsy assay using novel DNA methylation biomarkers for lung cancer detection and disease monitoring.
Fields of Study & Subjects
Cancer Genomics and Diagnostics
Epigenetics and DNA Methylation
Lung Cancer Diagnosis and Treatment
Publication details
- Journal / source
- ESMO Open
- Volume
- 11
- Pages
- 105993–105993
- Publication date
- 1 February 2026
- Language
- EN